Literature DB >> 8557976

Delineation of IL-5 domains predicted to engage the IL-5 receptor complex.

R R Dickason1, M M Huston, D P Huston.   

Abstract

IL-5 is an interdigitating homodimeric glycoprotein and a member of the helical bundle family of cytokines. IL-5 is a potent activator of eosinophils and a specific promoter of their differentiation. This activity has implicated IL-5 in the pathogenesis of asthma and allergic disease. A detailed understanding of IL-5 structure and function is required to develop immunomodulators of IL-5-mediated inflammatory responses. We generated a panel of neutralizing anti-IL-5 mAbs which were used to map functional domains on IL-5. In addition, the nucleotide sequences for human IL-5, murine IL-5, rat IL-5, and eight human/murine IL-5 chimeras were engineered and expressed in COS-7 cells. These recombinant cytokines and mAbs were used in TF-1 bioassays to identify five functional epitopes on the tertiary structure of IL-5. Residues responsible for the species-specific activity of human IL-5 were identified with the murine BCL1 bioassay. One set of epitopes cluster around the helix A-loop 2 region, which is predicted to engage the IL-5 receptor beta-chain. The second set of epitopes as well as the species specificity domain cluster around the loop 3-helix D region, which is predicted to engage the IL-5 receptor alpha-chain. Together, these analyses target the A/D helical face of IL-5 as the region involved in receptor engagement.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8557976

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  5 in total

Review 1.  Interleukin-5, a therapeutic target in allergic inflammation.

Authors:  D P Huston; M M Huston; R R Dickason; M Martinez-Moczygemba
Journal:  Trans Am Clin Climatol Assoc       Date:  2000

Review 2.  Therapeutic strategies for harnessing human eosinophils in allergic inflammation, hypereosinophilic disorders, and cancer.

Authors:  Zhaleh J Amini-Vaughan; Margarita Martinez-Moczygemba; David P Huston
Journal:  Curr Allergy Asthma Rep       Date:  2012-10       Impact factor: 4.806

3.  Engineering of a functional interleukin-5 monomer: a paradigm for redesigning helical bundle cytokines with therapeutic potential in allergy and asthma.

Authors:  R R Dickason; J D English; D P Huston
Journal:  J Mol Med (Berl)       Date:  1996-09       Impact factor: 4.599

4.  Expression and in vitro properties of guinea pig IL-5: comparison to human and murine orthologs.

Authors:  C W Scott; C Budzilowicz; S J Hubbs; M Stein; C Sobotka-Briner; D E Wilkins
Journal:  Mediators Inflamm       Date:  2000       Impact factor: 4.711

Review 5.  Th2 cytokines and asthma. The role of interleukin-5 in allergic eosinophilic disease.

Authors:  S Greenfeder; S P Umland; F M Cuss; R W Chapman; R W Egan
Journal:  Respir Res       Date:  2001-03-08
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.